Fear-based campaign ads can...

On a Monday night in September 1964, television...

Scientists discover a hidden...

Deep within the brainstem is a tiny group of nerve cells that...

Biomarkers for the in...

Alzheimer's disease (AD) causes gradual cognitive decline and dementia. Until recently, the definitive...

Delhi AQI Worsens After...

Delhi's AQI turns poor after Dussehra, prompting the start of...
HomeVIDEOSAdvances in treatment...

Advances in treatment in the fight against Alzheimer’s disease



The number of Americans with Alzheimer’s disease is expected to double from 7 million in 2020 to 14 million by 2060, according to the CDC. However, advances in treatment options are giving more people hope in slowing the decline. Dr. Jon LaPook breaks it down.

Each weekday morning, “CBS Mornings” co-hosts Gayle King, Tony Dokoupil and Nate Burleson bring you the latest breaking news, smart conversation and in-depth feature reporting. “CBS Mornings” airs weekdays at 7 a.m. on CBS and stream it at 8 a.m. ET on the CBS News app.

Subscribe to “CBS Mornings” on YouTube:
Watch CBS News 24/7:
Download the CBS News app:
Follow “CBS Mornings” on Instagram:
Like “CBS Mornings” on Facebook:
Follow “CBS Mornings” on X:
Subscribe to our newsletter:
Try Paramount+ free:

For video licensing inquiries, contact: licensing@veritone.com

source

Continue reading

Fear-based campaign ads can grab attention, but whether they win votes is less clear

On a Monday night in September 1964, television viewers watched a little girl counting petals on a flower. Her voice gave way to a man counting down, and then a nuclear blast filled the...

Scientists discover a hidden messaging system deep inside the brain

Deep within the brainstem is a tiny group of nerve cells that plays an outsized role in how the brain functions. This region, called the locus coeruleus (LC), gets its name from the Latin words for "blue place."...

Biomarkers for the in vivo diagnosis of Alzheimer’s disease

Alzheimer's disease (AD) causes gradual cognitive decline and dementia. Until recently, the definitive diagnosis of AD was based on autopsy assessments of brain amyloid-β plaques and tau neurofibrillary tangles, the defining biological features of AD. Biomarkers of amyloid-β and...